A systematic review of the economic studies on vaccine against herpes zoster and postherpetic neuralgia in adults;Revisión sistemática de estudios económicos sobre la vacuna contra herpes zóster y neuralgia postherpética en adultos

Vacunas

Volumn 10, Issue 4, 2009, Pages 118-124

  Marquez Pelaez S ^a   Ruiz Aragon J ^a  

^a Andalusian Agency for Health Technology Assessment Spain   (Spain)

Author keywords

Cost effectiveness; Cost utility; Economic evaluation; Herpes zoster; Postherpetic neuralgia; Vaccine

Indexed keywords

PLACEBO; VARICELLA ZOSTER VACCINE;

ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DECISION MAKING; DRUG EFFICACY; FINANCIAL MANAGEMENT; HEALTH CARE SYSTEM; HERPES ZOSTER; HUMAN; POSTHERPETIC NEURALGIA; SYSTEMATIC REVIEW; VACCINATION;

EID: 77950497991     PISSN: 15769887     EISSN: 15788857     Source Type: Journal    
DOI: 10.1016/S1576-9887(09)73477-6     Document Type: Article

References (23)

1. Ruiz-Aragón J, Villegas R. Vacuna para la prevención de herpes zóster y neuralgia postherpética en adultos. Agencia de Evaluación de Tecnologías Sanitarias, Sevilla.
2. Jl. Jackson, R. Gibson, G. Meyer, and L. Intuye The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia: a meta-analysis Arch Inter Med 157 1997 909 912 (Pubitemid 28337042)
3. Hervás A, Forcén T. Herpes zóster y neuralgia postherpética. [Accedido Junio 2009]. Guías Clínicas. 2009;9. Disponible en: www.fisterra.com/guias2/Herpes.asp
4. M.A. Torrecilla, F. García, R. Rodríguez, and J. Ruiz La vacunación frente a herpes zóster Aten Primaria 41 2009 424 425
5. R.H. Dworkin, R. White, A.B. O'Connor, K. Hawkins, R.H. Dworkin, and R. White Health care expenditure burden of persisting herpes zoster pain Pain Med 9 2008 348 353 (Pubitemid 351467890)
6. M.S. Patel, A. Gebremariam, M.M. Davis, M.S. Patel, A. Gebremariam, and M.M. Davis Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States Infect Control Hosp Epidemiol 29 2008 1157 1163
7. A. Gauthier, J. Breuer, D. Carrington, M. Martin, V. Remy, A. Gauthier, et al. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom Epidemiol Infect 137 2009 38 47
8. A.N. Stein, H. Britt, C. Harrison, E.L. Conway, A. Cunningham, and C.R. Macintyre Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older Vaccine 27 2009 520 529
9. M.N. Oxman, M.J. Levin, G.R. Johnson, K.E. Schmader, S.E. Straus, L.D. Gelb, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults N Engl J Med 352 2005 2271 2284
10. Banco Central Europeo. Statistical Data Warehouse. [Accedido 15 Dic 2009]. Disponible en: www.ecb.int/stat/exchange
11. Instituto Nacional de Estadística. [Accedido 15 Dic 2009] Disponible en: www.ine.es
12. Critical Appraisal Skill Programme (CASP). [Accedido 27 Nov 2009] Disponible en: www.redcaspe.org
13. R.S. Chapman, W.C. Kenneth, and D.M. Fleming The incidente of shingles and its implications for vaccination policy Vaccine 21 2003 2541 2547 (Pubitemid 36561347)
14. K.J. Smith, and M. Roberts Cost effectiveness of vaccination strategies in adults without a history of chickenpox Am J Med 15 2000 723 729 (Pubitemid 30621460)
15. A.J. Van Hoek, N. Gay, A. Melegaro, W. Opstelten, and W.J. Edmunds Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales Vaccine 27 2009 1454 1467
16. M. Brisson, J.M. Pelliesier, S. Camdem, C. Quach, and P. De Wals The potencial cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia Human Vaccines 4 2008 230 245
17. J.M. Pellisier, M. Brisson, and M.J. Levin Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults Vaccine 25 2007 8326 8337 (Pubitemid 350087379)
18. M.B. Rothberg, A. Virapongse, and K.J. Smith Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults Clin Infect Dis 44 2007 1280 1288 (Pubitemid 46717289)
19. M.B. Horberger Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults Clin Infect Dis 45 2007 1280 1288 (Pubitemid 46717289)
20. W.J. Edmuns, M. Brisson, and J.D. Rose The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales Vaccine 19 2001 3076 3090 (Pubitemid 32324035)
21. W.J. Edmuns, G.F. Medley, and D.J. Nokes Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective Statis Med 18 1999 3263 3282
22. R. Pradas, F. Antoñanzas, and M.P. Martínez Dynamic modelling of infectious diseases: an application to the economic evaluation of influenza vaccination Pharmacoeconomics 26 2008 45 56
23. R. Pradas, F. Antoñanzas, and J. Mar Modelos matemáticos para la evaluación económica: los modelos dinámicos basados en ecuaciones diferenciales Gac Sanit 23 2009 473 478